More Remdesivir Data, More Questions Linger

 
• By Derrick Gingery
Coronavirus
Clinicians have some clues about the best patients for remdesivir, but say more information still is needed after studies were published. • Source: Shutterstock

More from Clinical Trials

More from R&D